Cite
MLA Citation
E. Chernyaeva et al.. “FRI0010 Pharmacokinetics, Safety and Tolerance of BCD-085, A Novel IL-17 Inhibitor, Based on The Results of Phase 1 Clinical Study in Healthy Volunteers.” Annals of the rheumatic diseases, vol. 75, n.d., p. 429. http://access.bl.uk/ark:/81055/vdc_100135138700.0x000054